These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32707231)

  • 1. Map kinase signaling as therapeutic target for neurodegeneration.
    Ahmed T; Zulfiqar A; Arguelles S; Rasekhian M; Nabavi SF; Silva AS; Nabavi SM
    Pharmacol Res; 2020 Oct; 160():105090. PubMed ID: 32707231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potency of mTOR signaling pharmacological inhibitors in the treatment of proinflammatory diseases, current status, and perspectives.
    Soltani A; Bahreyni A; Boroumand N; Roshan MK; Khazaei M; Ryzhikov M; Soleimanpour S; Avan A; Hassanian SM
    J Cell Physiol; 2018 Jun; 233(6):4783-4790. PubMed ID: 29165795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the JNK pathway for therapeutic benefit in CNS disease.
    Bozyczko-Coyne D; Saporito MS; Hudkins RL
    Curr Drug Targets CNS Neurol Disord; 2002 Feb; 1(1):31-49. PubMed ID: 12769633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LXW7 attenuates inflammation via suppressing Akt/nuclear factor kappa B and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells.
    Peng S; Jia J; Sun J; Xie Q; Zhang X; Deng Y; Yi L
    Int Immunopharmacol; 2019 Dec; 77():105963. PubMed ID: 31732449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK signalling: a possible target to prevent neurodegeneration.
    Borsello T; Forloni G
    Curr Pharm Des; 2007; 13(18):1875-86. PubMed ID: 17584114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPKs: new targets for neurodegeneration.
    Harper SJ; Wilkie N
    Expert Opin Ther Targets; 2003 Apr; 7(2):187-200. PubMed ID: 12667097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration.
    Peixoto CA; Oliveira WH; Araújo SMDR; Nunes AKS
    Exp Neurol; 2017 Dec; 298(Pt A):31-41. PubMed ID: 28844606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease.
    Le Pichon CE; Meilandt WJ; Dominguez S; Solanoy H; Lin H; Ngu H; Gogineni A; Sengupta Ghosh A; Jiang Z; Lee SH; Maloney J; Gandham VD; Pozniak CD; Wang B; Lee S; Siu M; Patel S; Modrusan Z; Liu X; Rudhard Y; Baca M; Gustafson A; Kaminker J; Carano RAD; Huang EJ; Foreman O; Weimer R; Scearce-Levie K; Lewcock JW
    Sci Transl Med; 2017 Aug; 9(403):. PubMed ID: 28814543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p38alpha mitogen-activated protein kinase as a central nervous system drug discovery target.
    Borders AS; de Almeida L; Van Eldik LJ; Watterson DM
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S12. PubMed ID: 19090985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target.
    Kaminska B; Gozdz A; Zawadzka M; Ellert-Miklaszewska A; Lipko M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1902-13. PubMed ID: 19943344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.
    Mehan S; Meena H; Sharma D; Sankhla R
    J Mol Neurosci; 2011 Mar; 43(3):376-90. PubMed ID: 20878262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic induction of autophagy to modulate neurodegenerative disease progression.
    Hochfeld WE; Lee S; Rubinsztein DC
    Acta Pharmacol Sin; 2013 May; 34(5):600-4. PubMed ID: 23377551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROCK inhibition in models of neurodegeneration and its potential for clinical translation.
    Koch JC; Tatenhorst L; Roser AE; Saal KA; Tönges L; Lingor P
    Pharmacol Ther; 2018 Sep; 189():1-21. PubMed ID: 29621594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed-lineage kinases: a target for the prevention of neurodegeneration.
    Wang LH; Besirli CG; Johnson EM
    Annu Rev Pharmacol Toxicol; 2004; 44():451-74. PubMed ID: 14744254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflamm-aging and neurodegenerative diseases: an overview.
    Pizza V; Agresta A; D'Acunto CW; Festa M; Capasso A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):621-34. PubMed ID: 21631404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological roles of MAPK signaling pathways in human diseases.
    Kim EK; Choi EJ
    Biochim Biophys Acta; 2010 Apr; 1802(4):396-405. PubMed ID: 20079433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38.
    Xie Z; Smith CJ; Van Eldik LJ
    Glia; 2004 Jan; 45(2):170-9. PubMed ID: 14730710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on pharmacological approaches to neurodegenerative diseases.
    Scatena R; Martorana GE; Bottoni P; Botta G; Pastore P; Giardina B
    Expert Opin Investig Drugs; 2007 Jan; 16(1):59-72. PubMed ID: 17155854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raf inhibitors as therapeutic agents against neurodegenerative diseases.
    Burgess S; Echeverria V
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):120-7. PubMed ID: 20201822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
    Maiese K
    Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.